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Background: Chromosome 9p21 variants are associated with cardiovascular disease (CVD) but not with any of its
known risk markers. However, recent studies have suggested that the risk associated with 9p21 variation is modified
by a prudent dietary pattern and smoking. We tested if the increased risk of CVD by the 9p21 single nucleotide
polymorphism rs4977574 is modified by intakes of vegetables, fruits, alcohol, or wine, and if rs4977574 interacts
with environmental factors on known CVD risk markers.
Methods: Multivariable Cox regression analyses were performed in 23,949 individuals from the population-based
prospective Malmö Diet and Cancer Study (MDCS), of whom 3,164 developed CVD during 15 years of follow-up.
The rs4977574 variant (major allele: A; minor allele: G) was genotyped using TaqMan® Assay Design probes. Dietary
data were collected at baseline using a modified diet history method. Cross-sectional analyses were performed in
4,828 MDCS participants with fasting blood levels of circulating risk factors measured at baseline.
Results: Each rs4977574 G allele was associated with a 16% increased incidence of CVD (95% confidence interval
(CI), 1.10–1.22). Higher vegetable intake (hazard ratio (HR), 0.95 [CI: 0.91–0.996]), wine intake (HR, 0.91 [CI: 0.86–0.96]),
and total alcohol consumption (HR, 0.92 [CI: 0.86–0.98]) were associated with lower CVD incidence. The increased
CVD incidence by the G allele was restricted to individuals with medium or high vegetable intake (Pinteraction = 0.043),
and to non- and low consumers of wine (Pinteraction = 0.029). Although rs4977574 did not associate with any known
risk markers, stratification by vegetable intake and smoking suggested an interaction with rs4977574 on glycated
hemoglobin and high-density lipoprotein cholesterol (Pinteraction = 0.015 and 0.049, respectively).
Conclusions: Our results indicate that rs4977574 interacts with vegetable and wine intake to affect the incidence
of CVD, and suggest that an interaction may exist between environmental risk factors and rs4977574 on known
risk markers of CVD.
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The single nucleotide polymorphisms (SNPs) on chromo-
some 9p21 identified by genome-wide association studies
are the strongest known to date to be associated with
coronary artery disease (CAD) [1-3] and myocardial
infarction (MI) [4,5]. Variants at this locus have also
been associated with abdominal aortic aneurysms, intra-
cranial aneurysms [6], and periodontitis [7]. Approxi-
mately 25% of the Caucasian population is homozygous
for an allele at this locus that confers a 30–40% increased
risk of developing CAD [2]. However, because this risk
increase is independent of all conventional risk factors
such as plasma lipoprotein levels, diabetes, hyperten-
sion, or markers of inflammation, the mechanism by
which the 9p21 locus confers risk remains poorly
understood [2,4].
Several dietary factors have been shown to associate
with cardiovascular disease (CVD). For instance, a dietary
intake of vegetables and nuts, and dietary patterns such as
the Mediterranean-like diet are associated with protection
against CVD, while an intake of trans-fatty acids, a high
glycemic load and glycemic index diets have shown harm-
ful effects [8]. Previous observations from the Malmö Diet
and Cancer Study (MDCS) found that a high quality diet
(i.e., in line with current dietary recommendations) is
associated with lower CVD risk [9]. Strong evidence from
the Nurses’ Health study and the Health Professionals’
Follow-up Study suggests that diets rich in vegetables and
fruits lower the risk of CVD [10]. Moreover, two large
meta-analyses combining prospective studies from the
United States and Europe confirmed the protective associ-
ation of higher fruit and vegetable intake with incident
CAD and stroke [11,12]. Additionally, moderate alcohol
and wine consumption has been recognized as protective
against CVD. Moderate alcohol intake has been associated
with a lower risk of multiple cardiovascular outcomes in
a systemic review and meta-analysis of 84 studies, while
high alcohol consumption was associated with increased
cardiovascular mortality and stroke incidence, consistent
with U- or J-shaped curves [13]. Compelling evidence
also exists for wine consumption providing a more pro-
nounced cardio-protective effect compared with other
alcoholic beverages [14,15].
A recent multi-ethnic study reported that the risk of
MI and CVD determined by 9p21 variants was modified
by a prudent diet score mainly driven by the raw vege-
table component [16]. Another MDCS finding was of
the reported interaction between 9p21 rs4977574 variant
and smoking on the CAD incidence: a strong association
was only observed among nonsmokers, while this associ-
ation was significantly attenuated among smokers [17].
In the present study, we tested if the associated effect
of the chromosome 9p21 rs4977574 variant on the risk
of CVD was modified by vegetable, fruit, wine, or totalalcohol intake. We further investigated whether these
environmental factors interacted with the 9p21 variant




The MDCS is a population-based prospective cohort in
the city of Malmö, Sweden. Individuals born between
1923 and 1950 were recruited from a source population
of 74,138 residing in Malmö with Swedish reading and
writing skills. The baseline examination period extended
between March 1991 and October 1996. Written informed
consent was obtained from all participants on their first
visit to the hospital and after receiving instructions about
the study procedures and questionnaires. Anthropomet-
rics, body composition, and blood pressure were directly
measured. Study participants were instructed on how to
fill in a diet questionnaire, a diet diary, and an extensive
questionnaire covering socioeconomic and lifestyle factors
including medical history, smoking habits, education,
and physical activity. Participants returned approximately
2 weeks later for a diet history interview. By the end of the
baseline examination period, complete dietary, anthro-
pometric, and lifestyle data had been collected on 28,098
participants. Details of the recruitment procedures are
described elsewhere [18].
We excluded individuals with prevalent CVD and dia-
betes. Prevalent CVD cases were identified as individuals
with a history of MI or stroke. Prevalent diabetes cases
were identified as individuals with a self-reported dia-
betes diagnosis or those on a self-reported anti-diabetic
regimen. Our study population included 23,949 individ-
uals free from CVD or diabetes with available DNA sam-
ples and successfully genotyped for the rs4977574 SNP
at the chromosome 9p21 locus.
Cross-sectional study
At baseline, 6,103 individuals were randomly selected from
the whole MDCS (N= 28,098) to participate in the Malmö
Diet and Cancer Cardiovascular Cohort (MDC-CC). These
individuals underwent additional baseline measurements
from fasting blood samples that included low-density
lipoprotein cholesterol (LDLC), high-density lipoprotein
cholesterol (HDLC), triglycerides (TG), fasting blood
glucose, and high sensitivity C-reactive protein (hsCRP).
From this population we excluded individuals with
prevalent diabetes, and prevalent CVD (identified as
before). Our cross-sectional study included 4,828 indi-
viduals with complete data on rs4977574 genotype, diet,
fasting blood tests, and blood pressure. The MDCS was
approved by the Ethical Committee at Lund University
(LU 51–90). All participants provided written informed
consent.
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Incident CVD cases were identified as individuals with
CAD (defined as fatal or nonfatal MI or death due to
ischemic heart disease) or individuals with fatal or non-
fatal stroke using three registers: the Swedish Hospital
Discharge Register, the Swedish Cause of Death Register,
and the Stroke Register of Malmö. The identification
of these register end-points has been described and
validated elsewhere [19-21]. The follow-up period for
the present study extended to December 31, 2010. MI
cases were defined using codes 410 and I21 of the 9th
and 10th revisions of the International Classification of
Diseases (ICD9 and ICD10), and the stroke cases were
defined using codes 430, 431, 434, and 436 of the ICD9,
and codes I60, I61, I63, and I64 of the ICD10. A total of
3,164 individuals developed CVD, 1,844 developed CAD,
and 1,556 developed stroke over a mean follow-up period
of 15 years.
Clinical measurements
A balance-beam scale was used to measure weight (in kg)
with subjects wearing light clothing and no shoes. A fixed
stadiometer was used to measure height (in cm). Body
mass index (BMI) was measured as weight (kg) divided
by height (m2). Waist circumference (in cm) was mea-
sured midway between the lowest rib margin and iliac
crest. Fasting serum lipids, whole blood glucose, glycated
hemoglobin (HbA1C), and inflammatory markers were
measured from blood samples drawn after an overnight
fast. Fasting blood glucose was converted to fasting plasma
glucose (FPG) by multiplying the values by 1.13. HbA1C
values were converted from the Swedish Mono-S standar-
dization system to the International Federation of Clinical
Chemistry and Laboratory Medicine (IFCC) units using
the following formula: IFCC = (10.11 ×Mono-S) − 8.94.
Samples were analyzed by routine standard methods at
the Department of Clinical Chemistry, Malmö University
Hospital. Fasting blood measurements were only available
in MDC-CC.
Dietary assessment
The MDCS had a specially designed modified diet history
method that consisted of a 7-day menu book, a 168-item
questionnaire, and a 45–60 min diet history interview. All
cooked meals, cold beverages including alcohol, medicinal
drugs, natural remedies, and nutrient supplements
consumed were recorded in the menu book. Partici-
pants recorded meal patterns, consumption frequencies,
and portion sizes of regularly consumed foods not
covered by the menu book in the questionnaire. A
48-page booklet was used to help participants estimate
portion sizes. Diet history interviews were performed by
trained interviewers, during which portion sizes and
dishes were estimated using a more extensive bookcontaining photographs. Participants were also asked
about their meal patterns, cooking methods, and food
choices.
The average daily intake of foods was calculated using
data from the menu book and diet questionnaire, then
converted into energy and nutrient intakes using the
MDC Food and Nutrient Database. This was designed for
the MDCS and was derived from the PC KOST2-93 data-
base of the Swedish National Food Administration [22,23].
In September 1994, the coding routines for dietary
data were modified slightly to shorten the interview time
(from 60 to 45 minutes). This resulted in two slightly
different method versions (before and after September
1994) without any major influence on the ranking of
individuals [23]. A method variable, classifying data
collected before and after September 1994, and a four-
category season variable (i.e. winter, spring, summer, and
autumn) were created and used as covariates to adjust
for variation in data collection over time. The relative
validity of the dietary assessment method in MDCS was
previously evaluated in a sample of 206 (105 women and
101 men) Malmö residents, aged 50–69 years. The refer-
ence method was based on weighed food records taken
for 3 days every second month over the course of 1 year.
Crude Pearson correlation coefficients for vegetable,
fruit, wine, and total alcohol intake were 0.68, 0.60, 0.50,
and 0.78, respectively, for men, and 0.58, 0.77, 0.65, and
0.83, respectively, for women [24,25].
The dietary exposure variables used were vegetables,
fruit, wine, and total alcohol intake. Vegetable intake
included all raw, dried, and cooked vegetables. Fruit
intake included all citrus and non-citrus fruits and berries,
in addition to dried fruits. The weights of dried fruits were
corrected for their lower water content. Fruit and
vegetable intakes were estimated as g per day and
ranked into tertiles. The wine variable included red,
white, and fortified wines. Non-consumers of wine
were defined as those reporting no consumption of
wine in the menu book, and indicating no consumption of
wine during the previous month in the questionnaire.
Wine non-consumers were categorized into a separate
group and the rest were stratified into two groups using
the median split. Total alcohol intake was classified
into the following four categories based on g of alcohol
consumed per day: abstainers (those reporting zero
consumption of alcohol in the menu book, and indicating
no consumption of alcohol in the previous year in the
questionnaire), low (<15 g/d in women or <20 g/d in
men), medium (15–30 g/d in women or 20–40 g/d in
men), and high (>30 g/d in women or >40 g/d in men).
This categorization was based on an assumption of
biological risk [26]. For sensitivity analysis, we ex-
cluded abstainers and created tertiles of total alcohol
consumption.
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Leisure time physical activity was assessed by an exten-
sive lifestyle questionnaire adapted from the Minnesota
Leisure Time Physical Activity Questionnaire. Partici-
pants estimated the amount of time (in min) they spent
performing each of 17 different physical activities per
week for each season. The duration was multiplied by
an intensity factor to create a physical activity score
that was divided into tertiles. Participants were also
classified as current smokers, former smokers, and
never-smokers. The education variable was created
by classifying participants according to their highest
educational level (≤8 years, 9–10 years, and 11–13
years at school, and university degree).
Genotyping
The chromosome 9p21 rs4977574 SNP (major allele:
A; minor allele: G) was genotyped using TaqMan®
Assay Design probes with a real-time PCR assay using
ABI-7900HT equipment (Applied Biosystems, Foster
City, CA) according to the manufacturer’s instructions.
The concordance rate was more than 99.9% in ran-
domly selected samples (20%) and the genotypes were
in Hardy–Weinberg equilibrium (P = 0.18). We selected the
rs4977574 for our study as this SNP provided the strongest
evidence for association with early-onset MI in a large
genome-wide association study (GWAS) by Kathiresan
et al. [5] and as the same SNP has earlier been used in
two other interaction studies [16,17]. This SNP is in
high linkage disequilibrium (r2 = 0.91–0.97) with the
four SNPs (rs10757278, rs1333049, rs10757274, and
rs2383206) originally identified in the discovery GWAS
studies [1,2,4].
Statistical analysis
PASW statistics version 21 software (SPSS Inc., Chicago,
IL) was used for statistical analyses. The prospective
additive genetic association of the chromosome 9p21
rs4977574 G allele with incident CVD was assessed
using a multivariable Cox proportional hazards model
adjusting for age and sex. In cross-sectional analyses,
cardio-metabolic traits and dietary intakes (dependent
variables) were examined according to rs4977574 geno-
type (independent variable) using linear regression ana-
lyses with adjustments for age and sex. Prospective
associations between tertiles of vegetable and fruit intakes,
categories of alcohol or wine intake, and incidence of
CVD were assessed in a multivariable Cox proportional
hazards model with adjustments for age, sex, total energy
intake, season, dietary assessment method, BMI, systolic
blood pressure (SBP), use of lipid-lowering medication,
use of anti-hypertensive medication, tertiles of leisure
time physical activity, smoking status, level of education,
and total alcohol intake categories when applicable. Incross-sectional analyses, cardio-metabolic traits and
dietary intakes (dependent variables) were examined
according to intake categories of vegetables, fruits, wine
and alcohol (independent variables), using a multivari-
able linear regression model with the same adjustments
as listed above.
Interactions between rs4977574 and tertiles of vege-
table and fruit intakes, and the categories of alcohol or
wine intake on incidence of CVD were tested by includ-
ing both the rs4977574 variable and the environmental
variables and their multiplicative factor in the multi-
variable models, using the same adjustments described
above. The tertiles of vegetable and fruit intakes and
the categories of wine and total alcohol intakes were
treated as continuous variables. Significant prospective
interactions between environmental factors and rs4977574
on the incidence of CVD were further explored by cross-
sectional interaction analyses between rs4977574 and
quantitative glycemic, lipid, and inflammatory traits
measured at baseline with the same adjustments described
above.
Because it may be argued that BMI, SBP, and the use
of lipid-lowering or anti-hypertensive medication could
be on the causal pathway and should not be included in
the adjustment models, we additionally performed all
of the above analyses excluding these variables as pos-
sible confounders. Additional analyses were performed
by mutually adjusting the analyses for correlated envir-
onmental factors such as vegetable and wine intake,
and wine consumption and total alcohol consumption.
The P values of the study were not corrected for multiple
comparisons; those < 0.05 were considered nominally sta-
tistically significant. All reported P values are two-sided.
Results
The rs4977574 G allele was associated with an increased
incidence of CVD (hazard ratio [HR]: 1.16 per G allele;
95% confidence interval [CI]: 1.10–1.22) in MDCS (Table 1),
while higher vegetable, wine, and total alcohol intakes
were associated with a decreased incidence of CVD
(HR, 0.95 [CI: 0.91–0.996], 0.91 [0.86–0.96], and 0.92
[0.86–0.98], respectively). Cross-sectional associations
of intakes of vegetables, fruits, wine and alcohol with
baseline levels of different cardio-metabolic biomarkers
are shown in Additional file 1: Table S1–S4.
The CVD risk increase by the rs4977574 G allele was
modified by vegetable and wine intakes (Pinteraction = 0.043
and 0.029, respectively) but not with fruit or total alcohol
intakes (Pinteraction = 0.69 and 0.73, respectively). The
association between the rs4977574 G allele and increased
incidence of CVD was restricted to the medium and high
tertiles of vegetable intake (Ptrend = 6 × 10
−8 and 0.0004,
respectively) and to non- and low consumers of wine
(Ptrend = 4 × 10
−7 and 0.0004, respectively). The inverse
Table 1 Characteristics of the Malmö Diet and Cancer Study population by rs4977574 genotype
rs4977574 genotype HR (95% CI)a Ptrend
AA AG GG or β (SE)b
Total number 7325 11777 4847
Sex (%women) 62.6 62.3 62.3
Incident CVD N (%) 863 (11.8) 1562 (13.3) 739 (15.3) 1.16 (1.10-1.22) 4 × 10−09
Age (years) 57.9 ± 7.7 57.9 ± 7.6 57.8 ± 7.7 −0.04 (0.07) 0.60
BMI (kg/m2) 25.7 ± 3.9 25.6 ± 3.9 25.7 ± 3.9 0.001 (0.035) 0.98
Waist (cm) 83.6 ± 15.6 83.4 ± 12.8 83.7 ± 16.7 0.02 (0.11) 0.87
SBP (mmHg) 141 ± 20 141 ± 20 141 ± 20 0.21 (0.17) 0.21
DBP (mmHg) 85 ± 10 85 ± 10 86 ± 10 0.03 (0.09) 0.76
FPG (mmol/L)c 5.63 ± 0.84 5.62 ± 0.72 5.66 ± 0.91 0.009 (0.016) 0.59
HbA1C (mmol/mol)
c 39.6 ± 4.94 39.6 ± 4.82 39.9 ± 5.32 0.13 (0.10) 0.19
LDLC (mmol/L)c 4.15 ± 1.00 4.19 ± 0.98 4.19 ± 0.97 0.02 (0.02) 0.33
HDLC (mmol/L)c 1.39 ± 0.37 1.40 ± 0.38 1.39 ± 0.36 0.001 (0.007) 0.85
Triglycerides (mmol/L)c 1.35 ± 0.73 1.32 ± 0.71 1.37 ± 0.90 0.002 (0.015) 0.48
hsCRPc 0.26 ± 0.43 0.24 ± 0.39 0.27 ± 0.48 0.003 (0.009) 0.67
Total energy intake (kcal/day) 2280 ± 652 2274 ± 653 2276 ± 653 −3.90 (5.26) 0.46
Vegetables (g/day) 180 ± 98 182 ± 100 180 ± 99 −0.18 (0.90) 0.85
Fruits (g/day) 196 ± 127 193 ± 125 197 ± 127 0.29 (1.14) 0.80
Wine (g/day) 41.2 ± 58.2 42.8 ± 70.0 42.5 ± 60.6 0.70 (0.55) 0.20
Alcohol (g/day) 10.6 ± 12.3 10.9 ± 12.7 10.8 ± 12.8 0.13 (0.11) 0.22
Data represented as mean ± standard deviation.
aMultivariable Cox proportional hazards model for incidence of cardiovascular disease (CVD) during follow-up adjusting for age and sex with HR referring to hazard
ratio per risk G allele using an additive genetic model.
bLinear regression analyses of rs4977574 G allele using an additive genetic model with quantitative traits or characteristics at baseline adjusting for age and sex
when appropriate with β referring to associated effect estimate per risk G allele.
cIn MDC-CC only, N = 4,828 (AA N = 1,460; AG N = 2,381; GG N = 987).
CI, Confidence Interval; CVD, cardiovascular disease; SE, standard error; BMI, Body Mass Index; SBP, Systolic Blood Pressure; DBP, Diastolic Blood Pressure; FPG,
Fasting Plasma Glucose; HbA1C, Hemoglobin A1C; LDLC, Low-Density Lipoprotein Cholesterol; HDLC, High-Density Lipoprotein Cholesterol; hsCRP, High-Sensitivity
C-Reactive Protein.
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incidence was restricted to individuals with no risk
alleles (AA genotype, Ptrend = 0.001), while the inverse
association between higher wine consumption and inci-
dence of CVD was restricted to carriers of rs4977574 G
alleles (Ptrend = 0.00009) (AG and GG genotypes, Ptrend =
0.01 and 0.001, respectively) (Table 2). Both vegetable
and wine intake modified the risk of both CAD and
stroke by rs4977574 variant in a similar fashion as
observed with total CVD. However, the tests of inter-
action did not reach statistical significance (Additional
file 1: Table S6 and S7).
Concerning interaction with alcohol consumption, we
observed that the HR for CVD incidence was lowest
among AG genotype carriers in the medium alcohol
intake group; however, this was not significantly different
from the other intake groups as the interaction was not
significant (Table 2). To determine if the lack of inter-
action between the total alcohol categories and rs4977574
on CVD risk was caused by an absence of statistical power,
and as a sensitivity analysis, we excluded abstainers andperformed an interaction analysis between tertiles of
alcohol consumption and rs4977574 on CVD risk and
observed that only among AG carriers the higher alco-
hol consumption associated with significantly lower in-
cidence of CVD. However, no significant interaction
was revealed (Additional file 1: Table S5).
Consistent with earlier studies, rs4977574 did not
associate with any of the known clinical or circulating
risk factors of CVD (Table 1). However, stratification by
environmental factors indicated that there was an inter-
action between rs4977574 and vegetable intake on base-
line HbA1C levels (Pinteraction = 0.015), as well as smoking
status on baseline HDLC levels (Pinteraction = 0.049)
(Additional file 1: Table S8). The rs4977574 G allele was
only associated with elevated baseline HbA1C levels in
individuals within the lowest vegetable intake tertile
(Ptrend = 0.009), and with lower HDLC among never-
smokers only (Ptrend = 0.045). Moreover, higher vegetable
intake was associated with lower HbA1C levels among G
allele carriers only (Ptrend = 0.0002) (Figure 1). Smoking
was strongly associated with lower HDLC levels in MDC-
Table 2 Hazard ratio for incident CVD in the Malmö Diet and Cancer Study (n = 23,949) according to rs4977574
genotype and dietary or alcohol intake categories
Hazard ratio (95% Confidence interval) Ptrend
b,d Pinteraction
e,f
AA AG GG Additive modelb,d
n 7325 11777 4847
Vegetables (g/day) 0.043, 0.049
Low 7952 1.29 (1.09–1.52) 1.22 (1.04–1.43) 1.50 (1.26–1.79) 1.06 (0.98–1.14) 0.16
Medium 8041 0.87 (0.73–1.05) 1.27 (1.09–1.48) 1.41 (1.18–1.70) 1.27 (1.17–1.38) 5.6 × 10−8
High 7956 1.00 (ref)a,e 1.20 (1.02–1.41) 1.43 (1.18–1.72) 1.19 (1.08–1.30) 0.0004
Per categoryc,e 0.86 (0.79–0.94) 0.98 (0.92–1.05) 0.99 (0.90–1.09)
Ptrend
c,e 0.001 0.61 0.83
Fruits (g/day) 0.69, 0.80
Low 7886 1.10 (0.93–1.30) 1.26 (1.09–1.46) 1.51 (1.27–1.80) 1.16 (1.07–1.26) 0.0004
Medium 8030 1.13 (0.96–1.34) 1.25 (1.08–1.45) 1.46 (1.23–1.74) 1.14 (1.04–1.24) 0.003
High 8033 1.00 (ref) 1.24 (1.07–1.44) 1.44 (1.21–1.72) 1.18 (1.08–1.29) 0.0002
Per category 0.97 (0.89–1.06) 0.98 (0.92–1.05) 1.00 (0.90–1.10)
Ptrend 0.48 0.52 0.92
Wine (g/day) 0.029, 0.031
Non-consumers 6843 1.03 (0.86–1.22) 1.27 (1.09–1.49) 1.57 (1.32–1.88) 1.23 (1.14–1.34) 4 × 10−7
Low 8472 0.93 (0.78–1.11) 1.14 (0.98–1.33) 1.29 (1.08–1.59) 1.16 (1.07–1.26) 0.0004
High 8634 1.00 (ref) 1.01 (0.87–1.17) 1.17 (0.98–1.40) 1.08 (0.98–1.18) 0.11
Per category 0.97 (0.88–1.08) 0.91 (0.85–0.98) 0.84 (0.75–0.93)
Ptrend 0.61 0.01 0.001
Alcohol (g/day) 0.73, 0.86
Abstainers 1448 1.19 (0.78–1.81) 1.63 (1.11–2.39) 2.26 (1.49–3.42) 1.34 (1.13–1.60) 0.001
Low 17331 1.14 (0.81–1.60) 1.36 (0.97–1.91) 1.47 (1.04–2.08) 1.14 (1.07–1.20) 0.00002
Medium 4150 1.18 (0.81–1.70) 1.06 (0.74–1.52) 1.64 (1.13–2.37) 1.15 (1.02–1.30) 0.03
High 1020 1 (ref) 1.23 (0.82–1.85) 1.57 (0.99–2.50) 1.29 (1.02–1.63) 0.04
Per category 0.98 (0.87–1.10) 0.85 (0.78–0.93) 0.96 (0.85–1.09)
Ptrend 0.74 0.0004 0.57
aMultivariable Cox proportional hazards model for incidence of cardiovascular disease (CVD) during follow-up with hazard ratio per each category of rs4977574
genotype and food or beverage intake assuming the highest category and AA genotype as reference.
bMultivariable Cox proportional hazards model for incidence of cardiovascular disease (CVD) during follow-up with hazard ratio per risk G allele using an additive
genetic model.
cMultivariable Cox proportional hazards model for incidence of cardiovascular disease (CVD) during follow-up with hazard ratio per each higher food or beverage
intake category with the lowest intake category as reference.
dAdjusted for age and sex.
eAdjusted for age, sex, BMI, SBP, season, method, total energy intake, leisure time physical activity, alcohol intake, smoking status, education, lipid lowering and
antihypertensive treatment.
fExcluding BMI, SBP, antihypertensive and lipid lowering treatment from the adjustment model.
Hindy et al. BMC Medical Genetics  (2014) 15:1220 Page 6 of 10CC (Ptrend = 1× 10
−10), and the magnitude of this associ-
ation was largest among individuals carrying no risk alleles
(AA genotype, Ptrend = 1 × 10
−7) (Figure 2).
Discussion
In this prospective study, we observed that dietary
vegetable and wine intake modified the association of
the chromosome 9p21 rs4977574 variant with CVD
incidence. As expected, carriers of the rs4977574 G
allele were associated with an increased incidence
of CVD. Furthermore, a higher vegetable intake andmoderate or high wine and alcohol consumption were
associated with a lower incidence of CVD. However,
the increased incidence of CVD among G allele carriers
was restricted to individuals with a medium or high
vegetable intake and to individuals reporting a zero or
low consumption of wine. When stratified by rs4977574
genotype, the higher vegetable intake was only associ-
ated with a lower incidence of CVD in individuals with
no risk alleles, while wine consumption was only associ-
ated with a lower incidence of CVD among risk allele
carriers.
Figure 1 Mean HbA1Clevels in tertiles of vegetable intake by
rs4977574 genotype in MDC-CC. The G allele was only associated
with elevated HbA1C levels among individuals in the lowest tertile of
vegetable intake (β = 0.48 mmol/mol, SE = 0.18 per G allele, P = 0.009).
Higher vegetable intake was only associated with lower HbA1C among
individuals with AG (β = −0.28 mmol/mol, SE = 0.12 per risk tertile,
P = 0.019) and GG genotypes (β = −0.43 mmol/mol, SE = 0.20 per risk
tertile, P = 0.032).
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associate with any of the traditional clinical risk factors
in the present study. However, stratification by vegetable
intake and smoking status suggested that it may associate
with some of these risk factors, depending on the envir-
onment. We observed that presence of the G allele was
associated with elevated HbA1C levels among individ-
uals in the lowest tertile of vegetable intake. Further, the
G allele was only associated with lower HDLC levels
among never-smokers. These nominally significant in-
teractions indicate that the risk increase by 9p21 genetic
variation may at least partially be mediated throughFigure 2 Mean HDLC levels in smoking status categories by
rs4977574 genotype in MDC-CC. The G allele was only associated
with lower levels of HDLC among never-smokers (β = −0.02 mmol/L,
SE = 0.008 per G allele, P = 0.045). Higher risk categories of smoking
were associated with lower HDLC for all genotypes. The magnitude
of this association was largest among individuals with AA genotype
(β = −0.05 mmol/L, SE = 0.01 per higher risk category, P = 1 × 10−7)
compared with AG (β = −0.03 mmol/L, SE = 0.009 per higher risk
category, P = 0.0004) and GG (β = −0.02 mmol/L, SE = 0.01 per higher
risk category, P = 0.024) genotypes.deleterious effects on glucose and lipid metabolism,
dependent on environmental risk factors of CVD.
Multiple interactions were observed between the
rs4977574 variant and vegetable and wine intake with
respect to CVD incidence. Concerning vegetable intake,
the association with the genetic variant was attenuated
and not significant among individuals at higher CVD
risk because of low vegetable intake. This result is in
line with our earlier observation that the associated
effect of the 9p21 rs4977574 G allele was attenuated
and not significant among smokers, i.e. among individ-
uals already at higher risk because of an environmental
risk factor for CVD [17]. Of further relevance to this are
the results of an earlier study that reported an inter-
action between the 9p21 variant and a prudent diet
score [16]. However, in contrast to our results, the asso-
ciated effect of the risk allele was strongest among indi-
viduals in the lowest tertile of the prudent diet score.
We also observed that wine intake was associated with a
lower incidence of CVD, and that the risk increase
caused by presence of the G allele was attenuated
among consumers of wine. It therefore appears that the
attenuation of the risk by the 9p21 variant may be medi-
ated by both environmental risk factors (such as smok-
ing and low vegetable intake) and protective factors
(such as high wine intake) for CVD. Interaction analyses
on CAD and stroke indicated similar tendencies with
both vegetable and wine intake. However, due to de-
creased power in these subgroup analyses, statistical
significance could not be attained. We did not find
interaction with total alcohol intake although we ob-
served the AG carriers to have lowest risk of CVD in
the medium alcohol intake group and a strongly signifi-
cantly decreased incidence of CVD by increased alcohol
intake only among the AG genotype carriers.
It is important to recognize that vegetable and wine
intakes are positively correlated and could reflect the
same underlying interaction. However, when we mutu-
ally adjusted the analyses for these factors, the results
remained similar. It is also of interest that the inter-
action between the 9p21 variant and wine intake on
CVD risk was independent of total alcohol consumption,
because an adjustment for total alcohol intake did not
affect this result. Furthermore, adjusting for smoking
status did not change the observed interactions between
rs4977574 and vegetable or wine intake, indicating that
these interactions are independent.
The mechanisms by which the 9p21 locus confers an
increased risk of CVD remain incompletely understood.
The SNPs in this locus are located in a 53-kb linkage
disequilibrium (LD) block that lacks any protein-coding
genes [2,4]. However, the large noncoding RNA anti-
sense noncoding RNA in the INK locus (ANRIL) (also
known as CDKN2BAS) has been mapped to the risk
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robustly associate with the 9p21 genotype and with the
severity of atherosclerosis [29-32]. Although there is no
conclusive evidence about the potential connection
between ANRIL and CVD, several studies suggest a
possible role in the epigenetic regulation of gene ex-
pression, and support ANRIL as the effector gene in
9p21 [33-36]. Interestingly, several of the bioactive
compounds that have been recognized in nutritional
epigenetics are found in wine and vegetables such as
resveratrol (in red grapes), sulforaphane (in broccoli and
sprouts), butyrate (a fermentation product of dietary fiber),
and genistein (in fava beans and soya beans) [37-39]. If
epigenetic mechanisms contribute to the association
between 9p21 and CVD, our results suggest that they could
potentially be influenced by nutritional or environmental
factors and through gene–environment interactions.
It is noteworthy that an independent SNP in the
CDKN2A/B locus near the 9p21 53-kb LD block has
been robustly associated with type 2 diabetes [40,41].
This is particularly intriguing because we observed the
rs4977574 risk allele to associate with elevated HbA1C
levels among individuals with a lower vegetable intake.
Additionally, another interaction was observed between
the 9p21 variant and HbA1C on the risk of CAD in indi-
viduals with type 2 diabetes [42], such that the risk in-
crease of CAD by the 9p21 risk variant was accentuated
in individuals with elevated HbA1C levels.
Our study has a number of limitations, which should
be taken into account when analyzing results. First, base-
line diet data were projected onto the entire follow-up
period in the prospective analyses of CVD risk. Second,
the inaccurate reporting of alcohol consumption is a
known limitation in epidemiological studies, so could
be a potential weakness [25]. Third, the cross-sectional
analyses with CVD risk markers suffer from limited
causal inference. Fourth, we did not correct the statis-
tical analyses for multiple comparisons because the
dietary variables are correlated. However, despite these
limitations, the interactions observed between chromo-
some 9p21 variants and vegetable intake are supported
by previous findings in the case/control INTERHEART
study and the prospective FINRISK study [16]. Never-
theless, we should keep in mind that the observed
significance levels of the interactions in our study were
not very robust, so the possibility of false-positive find-
ings cannot be excluded. On the other hand, our study
has many important major strengths, including the
high relative validity of our dietary assessment method,
the combination of a diet diary with a questionnaire,
the large sample size, the prospective design, the
extensive follow-up of individuals through registers,
and the comprehensive ascertainment and verification
of CVD cases.Conclusions
Our results suggest that the chromosome 9p21 SNP
rs4977574 interacts with several environmental risk
factors to affect the incidence of CVD. Furthermore,
the observed modifications of the association between
rs4977574 and HbA1C and HDLC levels by vegetable
intake and smoking, respectively, provide evidence that
the risk increase may include environmental interac-
tions leading to derangements at the level of glucose
and lipid metabolism.
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